Long-term efficacy and safety of danicopan as add-on therapy to ravulizumab or eculizumab in PNH with significant EVH. Kulasekararaj A, Griffin M, Piatek C, Shammo J, et al. Blood 2025;145:811-822.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kulasekararaj A, Griffin M, Piatek C, Shammo J, et al. Long-term efficacy and safety of danicopan as add-on therapy to ravulizumab or eculizumab in PNH with significant EVH. Blood 2025;145:811-822.
PMID: 39700502